GE HealthCare Technologies Inc. Announces Appointment of Kevin A. Lobo to Board of Directors

Key Developments:

• GE HealthCare Technologies Inc. (NASDAQ: GEHC) announced the appointment of Kevin A. Lobo to its Board of Directors, effective March 13, 2026.
• On the same day, two sitting directors, Risa Lavizzo-Mourey and Tomislav Mihaljevic, announced they would not seek re-election at the 2026 Annual Meeting of Stockholders due to other commitments. The company noted that their decisions were not the result of any disagreement with the company’s operations, policies, or practices.

Details on the New Director:

• Kevin A. Lobo is a seasoned executive with significant experience in healthcare technology and global leadership. In the company’s words, “GE HealthCare plays a critical role in shaping the future of healthcare through advanced technology, novel pharmaceutical diagnostics, and global reach,” Lobo said. He expressed his eagerness to serve on the Board and work with management to drive growth, enable more precise patient care, and create long-term value.
• There are no arrangements or understandings between Mr. Lobo and any other person pursuant to which he was selected as a director. There are also no reportable transactions between Mr. Lobo and the company under Item 404(a) of Regulation S-K, providing comfort to shareholders that there are no related party issues associated with his appointment.

Shareholder-Relevant and Potentially Price-Sensitive Points:

• Board Refreshment and Leadership Change: The appointment of a new director with deep healthcare experience, combined with the departure of two established directors, signals a significant refresh at the Board level. Such changes often precede or accompany shifts in strategy, governance, or business focus, which can be material for investors.
• Strategic Direction: Mr. Lobo’s background and the company’s emphasis on advanced technology, pharmaceutical diagnostics, and global reach imply a continued and possibly enhanced focus on innovation and international expansion. Investors should monitor for subsequent announcements regarding strategic initiatives, partnerships, or product launches influenced by Board changes.
• No Disagreement or Governance Issues: The departing directors’ resignations were explicitly not due to any disagreements regarding company operations, policies, or practices, minimizing the risk of underlying governance disputes that could unsettle the stock.
• Ongoing Communications: GE HealthCare issued a press release regarding the appointment, indicating a commitment to transparency and regular investor communications. The press release is available as Exhibit 99 in the company’s regulatory filing.

About GE HealthCare Technologies Inc.:

GE HealthCare is a leading global provider of advanced medical technology, pharmaceutical diagnostics, and AI-driven solutions supporting clinicians in diagnosing and treating complex diseases. The company generated \$20.6 billion in revenue and employs approximately 54,000 people worldwide. It serves customers in more than 160 countries and is recognized among the 2026 Fortune World’s Most Admired Companies.

GE HealthCare’s solutions span imaging, advanced visualization, patient care, and pharmaceutical diagnostics, with a focus on delivering personalized and precise patient care. The company continues to invest in AI, cloud, and software solutions to support the next era of medicine.

Key Contacts:

• Media Contact: Jennifer Fox, Head of External Corporate Communications (+1 414 530 3027, [email protected])
• Investor Relations: Carolynne Borders (+1 631 662 4317, [email protected])

For the latest news and perspectives, investors are encouraged to visit the company’s website or its LinkedIn, Facebook, and Instagram pages.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult their advisors before making any investment decisions. The content is based on publicly available filings and press releases as of the date indicated and may not reflect subsequent developments.

View GE HealthCare Technologies Inc. Historical chart here